Citation

Iscan S, Eygi B (2018) Neurologic and Renal Outcomes of Elective Proximal Aortic Repair and Current Cannulation Trends. Int J Clin Cardiol 5:128. doi.org/10.23937/2378-2951/1410128

Copyright

© 2018 Iscan S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

RESEARCH ARTICLE | OPEN ACCESSDOI: 10.23937/2378-2951/1410128

Neurologic and Renal Outcomes of Elective Proximal Aortic Repair and Current Cannulation Trends

Sahin Iscan* and Bortecin Eygi

Department of Cardiovascular Surgery, Katip Celebi University Izmir Ataturk Education and Research Hospital, Izmir, Turkey

Abstract

Background

We aimed to determine factors influencing neurologic dysfunction and acute kidney injury (AKI) in patients undergoing elective aortic aneurysm repair and we also investigated them according to cannulation sites.

Methods

From January 2012 to April 2018, 112 patients received proximal aortic repair. We used aortic arch, axillary and femoral artery cannulation. Antegrade cerebral protection and total circulatory arrest were used.

Results

We detected 6 (5.4%) transient and 6 (5.4%) permanent neurologic dysfunction. Peripheral arterial diseases, total bypass time, transfusion and AKI showed correlation with neurologic dysfunction. Peripheral arterial diseases and AKI were independent risk factors (p < 0.05). AKI was reported in 38 patients. Postoperative revision, cross-clamp time, total bypass time and total circulatory arrest showed correlation with AKI (p < 0.05). Patients with neurologic dysfunction (66%) and patients with AKI (63%) had more femoral cannulation.

Conclusion

Proximal aortic repair can be achieved with low morbidity and mortality using appropriate cerebral protection and cannulation technique. Neurologic dysfunction and AKI are important factors for aortic surgery and femoral cannulation has the highest risk for neurologic dysfunction and AKI.